<https://www.empr.com/home/news/prezista-approved-for-hiv-1-in-treatment-experienced-adults-with-no-drv-rams/>
<http://schema.org/description>
"Tibotec Therapeutics announced that Prezista (darunavir) has been approved for once-daily administration in combination with ritonavir for treating human immunodeficiency virus (HIV-1) in treatment-experienced adults with no darunavir resistance-associated mutations (DRV RAMs)."
<https://www.empr.com/home/news/prezista-approved-for-hiv-1-in-treatment-experienced-adults-with-no-drv-rams/>